Recombinant Microbial Strain for Stable PHA Production
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for industrial production of polyhydroxyalkanoic acid (PHA) copolymers, such as P(3HB-co-3HH), face challenges including low productivity, instability of transgenes, and the need for expensive carbon sources, limiting their practical application and commercial viability.
Innovation Solution
A recombinant microbial strain is developed by site-specifically substituting an exogenous polyhydroxyalkanoic acid synthase gene for the native gene on the chromosome of Ralstonia eutropha H16, using a mutant enzyme derived from Aeromonas caviae with specific amino acid substitutions, enabling stable high-level accumulation of PHA with improved productivity and flexibility in carbon source utilization.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If conventional methods are used to produce P(3HB-co-3HH) copolymer, then the polyester can be produced with some flexibility, but the productivity is low (cell production 4 g/L, polyester content 30%)
Solution Approach 1:
The patent applies parameter changes by substituting specific amino acids (Asn149Ser and Asp171Gly) in the PHA synthase enzyme to alter its catalytic properties. This enables the enzyme to efficiently incorporate 3HH monomers while maintaining high productivity (110.4 g/L cell production, 73.8% polyester content) and stability without requiring antibiotic selection pressure.
Solution Approach 2:
The patent replaces the mechanical system of plasmid-based gene expression with a chromosomal integration system. The PHA synthase gene is integrated into the chromosome of Ralstonia eutropha H16, eliminating the need for antibiotic maintenance and providing stable inheritance without selective pressure, thereby achieving both high productivity and reliability.
2Adaptability or versatility
If plasmid-based expression systems are used, then foreign genes can be introduced, but the transgenes are unstable and require antibiotic selection pressure
Solution Approach 1:
The patent merges the foreign PHA synthase gene with the host chromosome through integration. The gene is inserted into a specific chromosomal location and expressed under the control of native promoters, achieving stable inheritance without requiring antibiotic selection pressure while maintaining the desired PHA production capabilities.
Solution Approach 2:
The patent implements a self-service system where the chromosomally integrated PHA synthase gene provides stable expression without external antibiotic selection. The gene is maintained and expressed naturally through chromosomal inheritance, eliminating the need for continuous antibiotic pressure and enabling long-term stable production.
3Quantity of substance
If expensive carbon sources are used for PHA production, then high polyester content can be achieved, but the production cost increases
Solution Approach 1:
The patent applies parameter changes by modifying the PHA synthase enzyme's substrate specificity through amino acid substitution. This enables the enzyme to efficiently utilize cheaper carbon sources like glucose and fatty acids, achieving high polyester content (73.8%) while reducing production costs by eliminating the need for expensive carbon sources.
4Strength
If P(3HB) homopolymer is produced, then high crystallinity and strength are achieved, but the material is hard and brittle with limited application range
Solution Approach 1:
The patent creates a copolymer composite by incorporating two different monomer units (3HB and 3HH) into the polyester chain. The 3HB units provide strength and crystallinity, while the 3HH units introduce flexibility and reduce brittleness. This composite structure at the molecular level achieves both mechanical strength and flexibility, expanding the application range to include both rigid and flexible products.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The strain achieves significantly higher productivity and stability, producing P(3HB-co-3HH) with a polyester content of 73.8 wt% and cell productivity of 110.4 g/L without the need for antibiotics, facilitating large-scale industrial production at a lower cost.
Implementation Method 1
a mutant enzyme derived from Aeromonas caviae with specific amino acid substitutions, enabling stable high-level accumulation of PHA
Data Source
AI summary
The present invention provides a recombinant microbial strain capable of stably producing a polyhydroxyalkanoic acid (PHA) at a high production rate in an industrial fermentation process. The present invention also relates to a recombinant microbial strain prepared by substituting an exogenous polyhydroxyalkanoic acid synthase gene for a polyhydroxyalkanoic acid synthase gene on the chromosome of the microorganism.